The NIEHS held a Symposium on the Environmental Genome Project on 17-18 October 1997 at the National Institutes of Health in Bethesda, Maryland. The purpose of the meeting was to facilitate a free exchange of information about the Environmental Genome Project among "a diverse group of scientists working in the areas of genetics, gene-environment interactions, molecular epidemiology, and issues of genetic testing" (1) . After attending this meeting and reading the recent reports on the Environmental Genome Project in Science (2) and Nature (3), we are concerned that several important issues of interest to the readers of Environmental Health Perspectives are not being adequately addressed by the NIEHS.
The goal of the Environmental Genome Project is to "facilitate identification of functionally important polymorphisms in environment response genes that may determine differences in disease risks to environmental exposures" (1) . To this end, the NIEHS proposes to establish a repository of 1,000 anonymous DNA samples representing the population of the United States in order to Basic scientists have rarely had to address broad public policy issues resulting from their investigations, but genetics has increasingly become, like epidemiology, as much a tool for public health as a scientific discipline. The point on which everyone seems to agree is that improving public health is the primary goal of biomedical research. It will take careful thinking to ensure that the Environmental Genome Project serves this purpose. The goal of the initial phase of the Environmental Genome Project is to stimulate research in the area of polymorphism discovery. This phase of the project does not specifically seek to assign polymorphism frequency. An allele has to be present only once in the repository to be discovered, yet accurately estimating the frequency of an allele in different ethnic groups requires genotyping of large numbers of individuals. Once polymorphisms (or alleles) have been discovered, study groups can be held to consider the research required for assignment of allele frequency. While the Environmental Genome Project does not seek to assign allele frequencies, we are aware of the importance of accurate allele frequency estimates for future epidemiologic studies and the large sample sizes such estimates will require. It is important to consider whether the sample size selected by the Environmental Genome Project will provide sufficient power to discover most alleles relevant to gene-environment interactions. Clearly, sampling 500 to 1,000 individuals will be adequate to identify many new polymorphisms. As pointed out during the symposium, sampling this number of individuals is adequate to identify most of the polymorphisms occurring commonly in the U.S. population. All of the newly identified polymorphisms will have the potential to be involved in gene-environment interactions, although none of them will be guaranteed to be so involved. It is also clear that various combinations of alleles may uniquely collaborate in environmentally associated disease. These allele combinations will, of course, be present in the population at lower levels than each allele alone. As was clearly pointed out at the Environmental Genome Project symposium, studies of gene-environment or gene-gene interactions will require very large sample sizes. Planning for both the technical means of rapid genotyping and the large number of samples for future epidemiologic studies is a key component of the Environmental Genome Project.
In their letter, Loffredo, Silbergeld, and Parascandola mention the potential usefulness of the archived lymphocyte cell lines from the NHANES III study and they suggest that this collection has not been explored as a resource for DNA samples. In fact, NHANES III cell lines will be used by the Environmental Genome Project. A repository of samples is being identified by the National Human Genome Research Institute, National Institutes of Health, in partnership with the Centers for Disease Control and Prevention. More than onehalf of the repository of samples will be from NHANES III.
As pointed out by Loffredo, Silbergeld, and Parascandola, another challenge to the Environmental Genome Project is in the area of its ethical, legal, and social implications. Symposium attendees discussed this topic in detail. These issues are complex and many-layered. It is highly unlikely that all the layers and nuances of the issues have been uncovered or that they will become simpler as the project evolves. To do justice to this component of the Environmental Genome Project, it is essential that sensitivity to these issues is upheld and that an effort is made to foster and maintain an open dialogue on these implications with both the scientific and nonscientific community.
One of the responsibilities faced by the Environmental Genome Project is to provide the science base upon which society can make better informed risk management decisions. We The reanalysis of global trends in reported human sperm counts by Swan et al. (1) concluded that a decline in sperm densities was observed in the United States and in Europe (1971 Europe ( -1990 but not in non-Western countries (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) . The report notes that recent studies from Europe and the United States indicate large interregional differences in sperm density. Interregional differences noted in the United States (New York City vs. Los Angeles, CA) were as large as the reported differences in mean sperm density in 1938 versus 1990.
Regional heterogeneity should alert us to be cautious in interpreting temporal trends in reported sperm densities for each region (2) . The only completely certain conclusion from the analysis of Swan et al. (1) is that there is a significant trend over time for sperm density studies to be reported from locations in the United States and Europe with lower sperm densities, while such a trend was not observed in reported studies from non-Western countries.
This limited conclusion is consistent with the data from single center studies where interregional differences are not a likely confounding factor. Single center studies in Europe report that sperm densities have declined over the last [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] years in Belgium (3), Finland (necropsy study) (4), London (area served by the
